(Q40935735)

25 September 2017

title

Performance of AGO score for secondary cytoreduction in a high-volume U.S. center (English)

1 reference

25 September 2017

4

Michaela E McGree

1 reference

25 September 2017

3

Amy L Weaver

1 reference

25 September 2017

Jo Marie Tran Janco

1

1 reference

25 September 2017

Amanika Kumar

series ordinal

2

1 reference

25 September 2017

William A Cliby

series ordinal

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

30 January 2016

1 reference

25 September 2017

1 reference

25 September 2017

volume

141

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

140-147

1 reference

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

Secondary complete cytoreduction in recurrent ovarian cancer: benefit of optimal patient selection using scoring system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

Surgical cytoreduction for recurrent epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.01.027

10.1016/J.YGYNO.2016.01.027

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference